Analysis of NAT2 point mutations with biological microchips

Molecular Biology

Volumn 41, Issue 4, 2007, Pages 656-664

  Kozhekbaeva, Zh M ^a   Glotov, A S ^b   Gra, O A ^a   Goldenkova Pavlova, I V ^c   Bruskin, S A ^c   Agafonova, E E ^d   Markarova, E V ^d   Abdeev, R M ^d   Korsunskaya, I M ^d   Piruzyan, A L ^d   Barsky, V E ^a   Zasedatelev, A S ^a   Nasedkina, T V ^a  

^a ENGELHARDT INSTITUTE OF MOLECULAR BIOLOGY   (Russian Federation)

^b D O OTT RESEARCH INSTITUTE OF OBSTETRICS   (Russian Federation)

^c VAVILOV INSTITUTE OF GENERAL GENETICS   (Russian Federation)

^d CENTER FOR THEORETICAL PROBLEMS OF PHYSICOCHEMICAL PHARMACOLOGY   (Russian Federation)

Author keywords

Acetylators; Allelic variants; Diagnosis; Genetic predisposition; Multiplex PCR; Oligonucleotide microchip; Pharmacogenetics

Indexed keywords

EID: 34548444239     PISSN: 00268933     EISSN: 16083245     Source Type: Journal    
DOI: 10.1134/S0026893307040206     Document Type: Article

References (29)

1. Baranov V.S., Baranova E.V., Ivashchenko T.E., Aseev M.V., 2000. Genom cheloveka i geny "predraspolozhennosti" (vvedenie v prediktivnuyu meditsinu) (Human Genome and "Susceptibility Genes": Introduction to Predictive Medicine), St. Petersburg: Intermedika.
2. Maiorova O.A., Netrebenko O.K., Shumilov P.V. 2003. Effect of polymorphic enzyme systems on the development of oncological processes: Nutritiological aspects. Vopr. Gematol. Onkol. Immunopatol. Pediatr. 2, 45-48.
3. Jennne J.W. 1965. Partial purification and properties of the isoniazid transacetylase in human liver. Its relationship to the acetylation of p-aminosalicylic acid. J. Clin. Invest. 44, 1992-2002.
4. Turesky R.J., Lang N.P., Butler M.A., Teitel C.H., Kadlubar F.F. 1991. Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon. Carcinogenesis. 12, 1839-1845.
5. Hickman D., Pope J., Patil S.D., Fakis G., Smelt V., Stanley L.A., Payton M., Unadkat J.D., Sim E. 1998. Expression of arylamine N-acetyltransferase in human intestine. Gut. 42, 402-409.
6. Sadrieh N., Davis C.D., Snyderwine E.G. 1996. N-Acetyltransferase expression and metabolic activation of the food-derived heterocyclic amines in the human mammary gland. Cancer Res. 56, 2683-2687.
7. http://www.louisville.edu/medschool/pharmacology/NAT2.html.
8. Artamonov V.V., Lyubchenko L.N., Shabanov M.A., Nemtsova M.V., Zaletaev D.V. 2004. The association of NAT2 polymorphisms with sporadic breast cancer. Mol. Biol. 38, 457-462.
9. Deitz A.C., Rothman N., Rebbeck T.R., Hayes R.B., Chow W.H., Zheng W., Hein D.W., Garcia-Closas M. 2004. Impact of misclassification in genotype-exposure interaction studies: example of N-acetyltransferase 2 (NAT2), smoking, and bladder cancer. Cancer Epidemiol Biomarkers Prev. 13, 1543-1546.
10. Firozi P.F., Bondy M.L., Sahin A.A., Chang P., Lukmanji F., Singletary E.S., Hassan M.M., Li D. 2002. Aromatic DNA adducts and polymorphisms of CYP1A1, NAT2, and GSTM1 in breast cancer. Carcinogenesis. 23, 301-306.
11. Moshkalov A.V., Imyanitov E.N. 2002. Moleculargenetic determinants of susceptibility to psoriasis: A review. Dermatologiya. 2, 3-5.
12. Capon F., Novelli G., Semprini S., Clementi M., Nudo M., Vultaggio P., Mazzanti C., Gobello T., Botta A., Fabrizi G., Dallapiccola B. 1999. Searching for psoriasis susceptibility genes in Italy: Genome scan and evidence for a new locus on chromosome 1. J. Invest Dermatol. 112, 32-35.
13. Azarova V.N., Khamaganova I.V., Polyakov A.V. 2003. Genetics of psoriasis. Ross. Zh. Kozhn. Vener. Bolezn. 6, 29-33.
14. Gu J., Liang D., Wang Y., Lu C., Wu X. 2005. Effects of N-acetyl transferase 1 and 2 polymorphisms on bladder cancer risk in Caucasians. Mutat. Res. 581, 97-104.
15. Risch A., Wallace D.M., Bathers S., Sim E. 1995. Slow N-acetylation genotype is a susceptibility factor in occupational and smoking-related bladder cancer. Hum. Mol. Genet. 4, 231-236.
16. Schnakenberg E., Ehlers C., Feyerabend W., Werdin R., Hubotter R., Dreikorn K., Schloot W. 1998. Genotyping of the polymorphic N-acetyltransferase (NAT2) and loss of heterozygosity in bladder cancer patients. Clin. Genet. 53, 396-402.
17. Imyanitov E.N., Khanson K.P. 2003. Epidemiology and biology of bladder cancer. Prakt. Onkol. 4, 191-195.
18. Hein D.W. 2002. Molecular genetics and function of NAT1 and NAT2: Role in aromatic amine metabolism and carcinogenesis. Mutat. Res. 506-507, 65-77.
19. Kukes V.G. 2004. Metabolizm lekarstvennykh sredstv: kliniko- farmakologicheskie aspekty (Medicine Metabolism: Clinical and Pharmacological Aspects), Moscow: Reafarm.
20. Rais R.Kh, Gulyaeva L.F. 2003. Biologicheskie effekty toksicheskikh soedinenii: kurs lektsii (Lectures on Biological Effects of Toxic Compounds), Novosibirsk: Novosib. Gos. Univ.
21. Glotov A.S., Nasedkina T.V., Ivashchenko T.E., Baranov V.S., Yurasov R.A., Surzhikov S.A., Pan'kov S.V., Chudinov A.V., Baranov V.S., Zasedatelev A.S. 2005. Development of a biochip for analyzing polymorphism of the biotransformation genes. Mol. Biol. 39, 403-412.
22. Fedorova O.E., Sinitska O.N., Tikhomirova L.P., Vishnevskaya Ya.V., Zasedatelev A.S., Nasedkina T.V. 2006. Analysis of point mutations in the BRCA1 gene by hybridization with hydrogel microchips. Mol. Biol. 40, 31-36.
23. Gra O.A., Glotov A.S., Kozhekbaeva Zh.M., Makarova O.V., Samochatova E.V., Zasedatelev A.S., Nasedkina T.V. 2006. Experience in using biochips for analyzing CYP1A1 gene polymorphisms in child leukemias. Med. Genet. 46, 34-38.
24. Goldenkova-Pavlova I.V., Bruskin S.A., Abdeev R.M., Markarova E.V., Bigvava S.G., Radkevich L.A., Kurdanov Kh.A., Kozhekbaeva Zh.M., Glotov A.S., Gra O.A., Zasedatelev A.S., Nasedkina T.V., Piruzyan E.S. 2006. Comparative analysis of the results of N-acetylation polymorphism phenotyping and genotyping in humans. Genetika. 42, 1-8.
25. Johns M.B., Paulus-Thomas J.E. 1989. Purification of human genomic DNA from whole blood using proteinase K treatment followed by phenol-chlorophorm extraction. Anal. Biochem. 180, 276-278.
26. Fotin A., Drobyshev A., Proudnikov D., Perov A., Mirzabekov A. 1998. Parallel thermodynamic analysis of duplexes on oligodeoxyribonucleotide microchips. Nucleic Acids Res. 26, 1515-1521.
27. Delomenie C., Sica L., Grant D.M., Krishnamoorthy R., Dupret J.M. 1996. Genotyping of the polymorphic N-acetyltransferase (NAT2*) gene locus in two native African populations. Pharmacogenetics. 6, 177-185.
28. Vatsis K.P., Martell K.J., Weber W.W. 1991. Diverse point mutations in the human gene for polymorphic N-acetyltransferase. Proc. Natl. Acad. Sci. USA. 88, 6333-6337.
29. http://www.dsi.univ-paris5.fr/genatlas.